Hubei Zhenhua Chemical Co.,Ltd.
SSE:603067.SS
22.29 (CNY) • At close April 30, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 4,066.719 | 3,698.699 | 3,533.801 | 2,993.229 | 1,278.418 | 1,395.222 | 1,404.864 | 1,185.48 | 874.508 | 776.352 | 819.036 | 624.926 | 597.435 | 514.499 |
| Cost of Revenue
| 3,042.159 | 2,802.382 | 2,577.268 | 2,246.233 | 892.219 | 994.052 | 995.657 | 893.016 | 614.491 | 563.439 | 565.83 | 424.456 | 388.331 | 318.259 |
| Gross Profit
| 1,024.56 | 896.317 | 956.533 | 746.996 | 386.199 | 401.17 | 409.207 | 292.464 | 260.017 | 212.914 | 253.205 | 200.471 | 209.104 | 196.24 |
| Gross Profit Ratio
| 0.252 | 0.242 | 0.271 | 0.25 | 0.302 | 0.288 | 0.291 | 0.247 | 0.297 | 0.274 | 0.309 | 0.321 | 0.35 | 0.381 |
| Reseach & Development Expenses
| 128.346 | 114.61 | 106.319 | 82.742 | 43.001 | 49.837 | 50.879 | 38.696 | 27.123 | 24.858 | 30.027 | 23.63 | 21.981 | 0 |
| General & Administrative Expenses
| 227.429 | 259.38 | 131.266 | 101.366 | 80.271 | 78.22 | 54.8 | 41.306 | 45.675 | 33.725 | 43.568 | 34.628 | 81.091 | 83.016 |
| Selling & Marketing Expenses
| 14.748 | 18.385 | 30.403 | 25.091 | 18.23 | 50.997 | 51.9 | 44.336 | 34.838 | 25.419 | 19.458 | 11.124 | 7.315 | 3.88 |
| SG&A
| 242.178 | 297.977 | 161.669 | 126.458 | 98.5 | 129.216 | 106.7 | 85.642 | 80.513 | 59.144 | 63.026 | 45.752 | 88.406 | 86.895 |
| Other Expenses
| 105.805 | 54.016 | 157.778 | 153.068 | 71.276 | 72.806 | -2.714 | -0.204 | 5.436 | 21.506 | 22.794 | 23.209 | 3.571 | 9.487 |
| Operating Expenses
| 476.328 | 466.603 | 425.766 | 362.267 | 212.778 | 251.86 | 216.526 | 173.554 | 163.211 | 126.448 | 134.516 | 105.633 | 91.871 | 90.182 |
| Operating Income
| 548.232 | 429.714 | 487.824 | 349.155 | 171.807 | 155.563 | 170.192 | 110.961 | 86.893 | 70.165 | 98.648 | 78.583 | 103.864 | 109.815 |
| Operating Income Ratio
| 0.135 | 0.116 | 0.138 | 0.117 | 0.134 | 0.111 | 0.121 | 0.094 | 0.099 | 0.09 | 0.12 | 0.126 | 0.174 | 0.213 |
| Total Other Income Expenses Net
| -7.214 | -15.191 | -4.338 | -14.898 | -0.694 | 0.71 | -2.714 | -0.204 | 5.389 | 4.506 | 3.593 | 6.206 | -10.896 | 9.47 |
| Income Before Tax
| 541.018 | 414.523 | 483.486 | 334.257 | 171.113 | 156.273 | 167.478 | 110.757 | 92.297 | 74.67 | 102.241 | 84.789 | 106.337 | 119.285 |
| Income Before Tax Ratio
| 0.133 | 0.112 | 0.137 | 0.112 | 0.134 | 0.112 | 0.119 | 0.093 | 0.106 | 0.096 | 0.125 | 0.136 | 0.178 | 0.232 |
| Income Tax Expense
| 69.279 | 42.163 | 59.807 | 22.431 | 19.751 | 18.077 | 20.585 | 10.379 | 12.636 | 12.182 | 9.864 | 12.029 | 14.963 | 14.913 |
| Net Income
| 472.876 | 370.809 | 416.973 | 310.67 | 149.837 | 136.97 | 146.165 | 100.128 | 79.661 | 62.488 | 92.377 | 72.761 | 91.375 | 104.373 |
| Net Income Ratio
| 0.116 | 0.1 | 0.118 | 0.104 | 0.117 | 0.098 | 0.104 | 0.084 | 0.091 | 0.08 | 0.113 | 0.116 | 0.153 | 0.203 |
| EPS
| 0.94 | 0.74 | 0.83 | 0.63 | 0.35 | 0.32 | 0.47 | 0.24 | 0.23 | 0.19 | 0.29 | 0.22 | 0.28 | 0.35 |
| EPS Diluted
| 0.92 | 0.73 | 0.82 | 0.63 | 0.35 | 0.32 | 0.47 | 0.24 | 0.23 | 0.19 | 0.29 | 0.22 | 0.28 | 0.35 |
| EBITDA
| 783.895 | 644.872 | 708.156 | 536.009 | 258.694 | 242.792 | 240.998 | 182.882 | 165.427 | 149.111 | 174.527 | 141.953 | 120.065 | 99.722 |
| EBITDA Ratio
| 0.193 | 0.174 | 0.2 | 0.179 | 0.202 | 0.174 | 0.172 | 0.154 | 0.189 | 0.192 | 0.213 | 0.227 | 0.201 | 0.194 |